<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03988374</url>
  </required_header>
  <id_info>
    <org_study_id>ST-7700</org_study_id>
    <nct_id>NCT03988374</nct_id>
  </id_info>
  <brief_title>Clinical Efficacy Evaluation of Three Dentifrices</brief_title>
  <official_title>Clinical Efficacy Evaluation of Three Dentifrices Containing 35%, 20%, and 0% Sodium Bicarbonate on the Reduction of Plaque and Gingivitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Church &amp; Dwight Company, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Church &amp; Dwight Company, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical study to evaluate and compare the efficacy of two baking soda containing&#xD;
      dentifrices, containing 20% and 35% baking soda, to a non-baking soda dentifrice for their&#xD;
      ability to reduce gingivitis and plaque following 6-months of use.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 22, 2018</start_date>
  <completion_date type="Actual">August 24, 2018</completion_date>
  <primary_completion_date type="Actual">August 24, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Within-Treatment Whole-Mouth Score - Gingival Efficacy</measure>
    <time_frame>baseline, six weeks, 3 months and 6 months</time_frame>
    <description>Mean Within-Treatment Whole-Mouth Score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Within-Treatment Whole-Mouth Score - Gingival Bleeding Efficacy</measure>
    <time_frame>baseline, six week, three months, and six months</time_frame>
    <description>Mean Within-Treatment Whole-Mouth Score as measured by Gingival Bleeding Index (0=absence of bleeding after 30 seconds, 1= bleeding observed after 30 seconds, 2= bleeding occurs instantly). The scale ranges from 0-2.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Within-Treatment Whole-Mouth Score - Plaque Efficacy</measure>
    <time_frame>baseline, six weeks, three months, and six months</time_frame>
    <description>Mean Within-Treatment Whole-Mouth Score as measured by Plaque Index (0=no visible plaque, 1=separate flecks of plaque at the cervical margin of the tooth, 2=a thin, continuous band of plaque (up to 1mm wide) at the cervical margin, 3= a band of plaque wider than 1 mm but covering less than one-third of the crown, 4=plaque covering at least one-third but less than two-thirds of the crown, 5= plaque covering two-thirds or more of the crown). The scale ranges from 0-5.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">319</enrollment>
  <condition>Gingival Inflammation and Bleeding</condition>
  <condition>Dental Plaque</condition>
  <arm_group>
    <arm_group_label>0% Baking Soda Dentifrice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>20% Baking Soda Dentifrice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>35% Baking Soda Dentifrice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dentifrices</intervention_name>
    <description>Dentifrice on plaque, gingivitis, and bleeding.</description>
    <arm_group_label>0% Baking Soda Dentifrice</arm_group_label>
    <arm_group_label>20% Baking Soda Dentifrice</arm_group_label>
    <arm_group_label>35% Baking Soda Dentifrice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have provided written informed consent prior to being entered into the study.&#xD;
&#xD;
          -  Be between 18 and 70 years of age, male or female.&#xD;
&#xD;
          -  Have at least eighteen (18) natural teeth with scorable facial and lingual surfaces as&#xD;
             determined by the Examiner. Teeth that are grossly carious, orthodontically banded,&#xD;
             exhibiting general cervical abrasion and/or enamel abrasion, or third molars will not&#xD;
             be included in the tooth count.&#xD;
&#xD;
          -  Have a mean baseline plaque index score ≥ 1.95 as determined by the Soparkar&#xD;
             Modification of the Turesky Modification of the Quigley-Hein Plaque Index (Pl).&#xD;
&#xD;
          -  Have a mean baseline gingival index score of ≥ l.70 and ≤ 3.0 as determined by the&#xD;
             Modified Gingival Index (MGI).&#xD;
&#xD;
          -  Presence of ≥ 10 bleeding sites upon probing.&#xD;
&#xD;
          -  Agree not to have a dental prophylaxis or any other elective, non-emergency dental&#xD;
             procedures any time during the study.&#xD;
&#xD;
          -  Agree to abstain from the use of chewing gum, mouth rinses, any toothpaste other than&#xD;
             the study toothpaste, tooth whitening products (either professional or at home use)&#xD;
             and all other oral hygiene other than the study procedures for the duration of the&#xD;
             study.&#xD;
&#xD;
          -  Agree to refrain from all oral hygiene on the morning of each evaluation visit and to&#xD;
             refrain from eating, drinking, and smoking for 4 hrs, prior to each evaluation visit.&#xD;
&#xD;
          -  Agree to comply with the conditions and schedule of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Physical limitations or restrictions that might preclude normal tooth brushing.&#xD;
&#xD;
          -  Evidence of gross oral pathology, including widespread caries or chronic neglect,&#xD;
             extensive restoration, preexisting gross plaque or soft or hard tissue tumor of the&#xD;
             oral cavity.&#xD;
&#xD;
          -  Heavy supra- or subgingival calculus that might interfere with evaluations as&#xD;
             determined by the Investigator/Examiner.&#xD;
&#xD;
          -  Evidence of major oral hard or soft tissue lesions or trauma at the baseline visit as&#xD;
             determined by the Investigator/Examiner.&#xD;
&#xD;
          -  Conditions requiring antibiotic treatment prior to dental procedures.&#xD;
&#xD;
          -  History of uncontrolled diabetes or hepatic or renal disease, or other serious&#xD;
             conditions or transmittable diseases, (e.g. cardiovascular disease, AIDS).&#xD;
&#xD;
          -  Subjects with grossly carious, fully crowned, or extensively restored teeth,&#xD;
             orthodontic appliances, peri/oral piercings, or removable partial dentures.&#xD;
&#xD;
          -  Treatment with antibiotics within the 1-month period before the baseline examination,&#xD;
             or a condition that is likely to require antibiotic treatment over the course of the&#xD;
             trial.&#xD;
&#xD;
          -  Chronic treatment (2 weeks or more) with any medication known to affect periodontal&#xD;
             status (including phenytoin, calcium antagonists, cyclosporine, coumarin, nonsteroidal&#xD;
             anti-inflammatory drugs, and aspirin) within 1 month of the baseline examination. All&#xD;
             other medications for chronic medical conditions must have been initiated at least 3&#xD;
             months before enrollment.&#xD;
&#xD;
          -  Have severe periodontal disease or being actively treated for periodontal disease.&#xD;
&#xD;
          -  Having history of early-onset periodontitis or acute necrotizing ulcerative&#xD;
             gingivitis.&#xD;
&#xD;
          -  Concomitant periodontal therapy other than prophylaxis in the last 6 months.&#xD;
&#xD;
          -  Professional prophylaxis within 1 month prior to the baseline clinical evaluation.&#xD;
&#xD;
          -  Subjects who participated in a gingivitis study in the past month.&#xD;
&#xD;
          -  Daily use of chemotherapeutic antiplaque/antigingivitis products within the past 4&#xD;
             months.&#xD;
&#xD;
          -  History of significant adverse effects following use of oral hygiene products such as&#xD;
             toothpastes and mouthrinses.&#xD;
&#xD;
          -  Subjects who are allergic to any ingredients in the test or control product, as listed&#xD;
             on the IRB Safety Assessment.&#xD;
&#xD;
          -  Self-reported pregnancy and nursing since hormonal changes can exaggerate gingival&#xD;
             response to dental plaque.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>All Sum Research Center Ltd.</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L4W OC2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 4, 2019</study_first_submitted>
  <study_first_submitted_qc>June 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 17, 2019</study_first_posted>
  <results_first_submitted>April 19, 2021</results_first_submitted>
  <results_first_submitted_qc>July 27, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 23, 2021</results_first_posted>
  <last_update_submitted>July 27, 2021</last_update_submitted>
  <last_update_submitted_qc>July 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
    <mesh_term>Dental Plaque</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 30, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/74/NCT03988374/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>0% Baking Soda Dentifrice</title>
          <description>Dentifrice, not containing baking soda, evaluated for ability to reduce gingivitis and plaque following 6-months of use.</description>
        </group>
        <group group_id="P2">
          <title>20% Baking Soda Dentifrice</title>
          <description>Dentifrice, containing 20% baking soda, evaluated for ability to reduce gingivitis and plaque following 6-months of use.</description>
        </group>
        <group group_id="P3">
          <title>35% Baking Soda Dentifrice</title>
          <description>Dentifrice, containing 35% baking soda, evaluated for ability to reduce gingivitis and plaque following 6-months of use.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
                <participants group_id="P2" count="107"/>
                <participants group_id="P3" count="108"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="103"/>
                <participants group_id="P2" count="105"/>
                <participants group_id="P3" count="107"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>0% Baking Soda Dentifrice</title>
          <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
        </group>
        <group group_id="B2">
          <title>20% Baking Soda Dentifrice</title>
          <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
        </group>
        <group group_id="B3">
          <title>35% Baking Soda Dentifrice</title>
          <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="103"/>
            <count group_id="B2" value="105"/>
            <count group_id="B3" value="107"/>
            <count group_id="B4" value="315"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Age</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="103"/>
                    <count group_id="B2" value="105"/>
                    <count group_id="B3" value="107"/>
                    <count group_id="B4" value="315"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.07" lower_limit="18" upper_limit="70"/>
                    <measurement group_id="B2" value="47.50" lower_limit="18" upper_limit="70"/>
                    <measurement group_id="B3" value="47.32" lower_limit="18" upper_limit="70"/>
                    <measurement group_id="B4" value="46.3" lower_limit="18" upper_limit="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="103"/>
                    <count group_id="B2" value="105"/>
                    <count group_id="B3" value="107"/>
                    <count group_id="B4" value="315"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="80"/>
                    <measurement group_id="B4" value="229"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="103"/>
                    <count group_id="B2" value="105"/>
                    <count group_id="B3" value="107"/>
                    <count group_id="B4" value="315"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="103"/>
                    <measurement group_id="B2" value="105"/>
                    <measurement group_id="B3" value="107"/>
                    <measurement group_id="B4" value="315"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gingvial Efficacy</title>
          <description>Measure Description: Lobene Modified Loe-Silness Gingival Scoring Index (MGI) - gingival sites were visually scored at each visit on the buccal and lingual marginal gingivae and interdental papillae of all scorable teeth, using a scale of 0-4. Lower values represent a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="103"/>
                    <count group_id="B2" value="105"/>
                    <count group_id="B3" value="107"/>
                    <count group_id="B4" value="315"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.081" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="B2" value="2.094" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="B3" value="2.092" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="B4" value="2.089" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gingival Bleeding Efficacy</title>
          <description>Measure Description: Bleeding was assessed on all scorable buccal and lingual surfaces by inserting a periodontal probe into the gingival crevice and sweeping from the distal aspect to the mesial aspect around the tooth at a depth of approximately 1 mm and angle of approximately 60 degrees while in contact with the sulcular epithelium. Three areas (distobuccal, midbuccal and midlingual) were assessed around each tooth. Sites were scored at each visit using the Gingival Bleeding Index (GBI) as defined by Saxton and van der Ouderaa on a scale of 0-2. Lower values represent a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="103"/>
                    <count group_id="B2" value="105"/>
                    <count group_id="B3" value="107"/>
                    <count group_id="B4" value="315"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.165" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="B2" value="0.178" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="B3" value="0.189" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="B4" value="0.177" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Plaque Efficacy</title>
          <description>Measure Description: Plaque was scored at each visit using the Soparker modification of the Turesky Modification of the Quigley-Hein Plaque Index (PI) on all scorable buccal and lingual surfaces. Plaque was stained with disclosant and each tooth was divided into six areas for scoring on a scale of 0-5. A PI score for each subject was calculated by adding all individual site scores (6 per tooth) and dividing by the total number of sites scored (teeth x 6). Lower values represent a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="103"/>
                    <count group_id="B2" value="105"/>
                    <count group_id="B3" value="107"/>
                    <count group_id="B4" value="315"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.409" lower_limit="0" upper_limit="5"/>
                    <measurement group_id="B2" value="2.411" lower_limit="0" upper_limit="5"/>
                    <measurement group_id="B3" value="2.356" lower_limit="0" upper_limit="5"/>
                    <measurement group_id="B4" value="2.4" lower_limit="0" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Within-Treatment Whole-Mouth Score - Gingival Efficacy</title>
        <description>Mean Within-Treatment Whole-Mouth Score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.</description>
        <time_frame>baseline, six weeks, 3 months and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0% Baking Soda Dentifrice</title>
            <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
          </group>
          <group group_id="O2">
            <title>20% Baking Soda Dentifrice</title>
            <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
          </group>
          <group group_id="O3">
            <title>35% Baking Soda Dentifrice</title>
            <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Within-Treatment Whole-Mouth Score - Gingival Efficacy</title>
          <description>Mean Within-Treatment Whole-Mouth Score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="103"/>
                <count group_id="O2" value="105"/>
                <count group_id="O3" value="107"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.081" spread="0.096"/>
                    <measurement group_id="O2" value="2.094" spread="0.117"/>
                    <measurement group_id="O3" value="2.092" spread="0.106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.996" spread="0.138"/>
                    <measurement group_id="O2" value="1.919" spread="0.171"/>
                    <measurement group_id="O3" value="1.882" spread="0.174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.980" spread="0.155"/>
                    <measurement group_id="O2" value="1.841" spread="0.198"/>
                    <measurement group_id="O3" value="1.766" spread="0.229"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.946" spread="0.149"/>
                    <measurement group_id="O2" value="1.763" spread="0.209"/>
                    <measurement group_id="O3" value="1.653" spread="0.256"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Within-Treatment Whole-Mouth Score - Gingival Bleeding Efficacy</title>
        <description>Mean Within-Treatment Whole-Mouth Score as measured by Gingival Bleeding Index (0=absence of bleeding after 30 seconds, 1= bleeding observed after 30 seconds, 2= bleeding occurs instantly). The scale ranges from 0-2.</description>
        <time_frame>baseline, six week, three months, and six months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0% Baking Soda Dentifrice</title>
            <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
          </group>
          <group group_id="O2">
            <title>20% Baking Soda Dentifrice</title>
            <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
          </group>
          <group group_id="O3">
            <title>35% Baking Soda Dentifrice</title>
            <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Within-Treatment Whole-Mouth Score - Gingival Bleeding Efficacy</title>
          <description>Mean Within-Treatment Whole-Mouth Score as measured by Gingival Bleeding Index (0=absence of bleeding after 30 seconds, 1= bleeding observed after 30 seconds, 2= bleeding occurs instantly). The scale ranges from 0-2.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="103"/>
                <count group_id="O2" value="105"/>
                <count group_id="O3" value="107"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.165" spread="0.085"/>
                    <measurement group_id="O2" value="0.178" spread="0.129"/>
                    <measurement group_id="O3" value="0.189" spread="0.114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.149" spread="0.091"/>
                    <measurement group_id="O2" value="0.135" spread="0.122"/>
                    <measurement group_id="O3" value="0.122" spread="0.081"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.141" spread="0.088"/>
                    <measurement group_id="O2" value="0.116" spread="0.117"/>
                    <measurement group_id="O3" value="0.094" spread="0.067"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.129" spread="0.082"/>
                    <measurement group_id="O2" value="0.096" spread="0.104"/>
                    <measurement group_id="O3" value="0.069" spread="0.053"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Within-Treatment Whole-Mouth Score - Plaque Efficacy</title>
        <description>Mean Within-Treatment Whole-Mouth Score as measured by Plaque Index (0=no visible plaque, 1=separate flecks of plaque at the cervical margin of the tooth, 2=a thin, continuous band of plaque (up to 1mm wide) at the cervical margin, 3= a band of plaque wider than 1 mm but covering less than one-third of the crown, 4=plaque covering at least one-third but less than two-thirds of the crown, 5= plaque covering two-thirds or more of the crown). The scale ranges from 0-5.</description>
        <time_frame>baseline, six weeks, three months, and six months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>0% Baking Soda Dentifrice</title>
            <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
          </group>
          <group group_id="O2">
            <title>20% Baking Soda Dentifrice</title>
            <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
          </group>
          <group group_id="O3">
            <title>35% Baking Soda Dentifrice</title>
            <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Within-Treatment Whole-Mouth Score - Plaque Efficacy</title>
          <description>Mean Within-Treatment Whole-Mouth Score as measured by Plaque Index (0=no visible plaque, 1=separate flecks of plaque at the cervical margin of the tooth, 2=a thin, continuous band of plaque (up to 1mm wide) at the cervical margin, 3= a band of plaque wider than 1 mm but covering less than one-third of the crown, 4=plaque covering at least one-third but less than two-thirds of the crown, 5= plaque covering two-thirds or more of the crown). The scale ranges from 0-5.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="103"/>
                <count group_id="O2" value="105"/>
                <count group_id="O3" value="107"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.409" spread="0.220"/>
                    <measurement group_id="O2" value="2.411" spread="0.244"/>
                    <measurement group_id="O3" value="2.356" spread="0.240"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.280" spread="0.211"/>
                    <measurement group_id="O2" value="2.134" spread="0.259"/>
                    <measurement group_id="O3" value="2.026" spread="0.227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months 3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.251" spread="0.202"/>
                    <measurement group_id="O2" value="2.066" spread="0.260"/>
                    <measurement group_id="O3" value="1.907" spread="0.265"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.196" spread="0.191"/>
                    <measurement group_id="O2" value="1.925" spread="0.239"/>
                    <measurement group_id="O3" value="1.793" spread="0.287"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>0% Baking Soda Dentifrice</title>
          <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
        </group>
        <group group_id="E2">
          <title>20% Baking Soda Dentifrice</title>
          <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
        </group>
        <group group_id="E3">
          <title>35% Baking Soda Dentifrice</title>
          <description>Dentifrices: Dentifrice on plaque, gingivitis, and bleeding.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="103"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="107"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="103"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="105"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="107"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="103"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="105"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="107"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Primary discomforts</sub_title>
                <description>Mild oral mucosal sloughing</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="103"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="105"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="107"/>
              </event>
              <event>
                <sub_title>Primary discomforts</sub_title>
                <description>Mild Dry Mouth</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="103"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="105"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="107"/>
              </event>
              <event>
                <sub_title>Primary discomforts</sub_title>
                <description>Mild oral tingling/burning sensation</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="103"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="105"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="107"/>
              </event>
              <event>
                <sub_title>Primary discomforts</sub_title>
                <description>Mild sensitive/irritated gums/teeth</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="103"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="105"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="107"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Master service agreement and confidentiality agreement in place</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Annahita Ghassemi, PhD</name_or_title>
      <organization>Church &amp; Dwight Co., Inc</organization>
      <phone>6098061200</phone>
      <email>annhita.ghassemi@churchdwight.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

